Singulus Technologies AG

Interim / Quarterly Report • Aug 14, 2025

T h i n - F i l m C o a t i n g a n d Sur face Treatment

Report for the FIRST HALF 2025

Interim Report as of June 30, 2025 (unaudited)

TABLE OF CONTENT

Business Trends and Situation	03
Semiconductor Segment	04
Life Science Segment	05
Solar Segment	06
New business areas	07
Key Financial Figures	09
Order intake and order backlog	09
Revenue and earnings	09
Segment reporting	09
Balance sheet and liquidity	10
Equity	10
Cash flow	11
Risk Report	11
Summary of risks	11
Sales market risk	11
Financial risks	12
Project risks	13
Development of costs and prices	13
Financing of the company	13
Research and development	14
Employees	14
Share	14
Annual General Meeting	15
Annual financial statements for 2024	15
Balance Sheet	16
Income Statement	18
Statement of Comprehensive Income	19
Statement of Changes in Equity	20
Statement of Cash Flows	22
Annotations to the Interim Report	24
Affirmation of the Legal Representatives	31
Financial Key Figures	32
Corporate Calendar	32
Future-oriented Statements and Forecasts	32

BUSINESS TRENDS AND SITUATION OF THE SINGULUS TECHNOLOGIES GROUP

SINGULUS TECHNOLOGIES AG Publishes Preliminary Financial Figures for the First Half of 2025

SINGULUS TECHNOLOGIES AG announces preliminary financial figures for the first half of 2025. During this period, the company generated sales of € 31.3 million (previous year: € 40.7 million). In the second quarter of 2025, sales amounted to € 14.9 million, compared to € 20.1 million in the same period last year.

EBIT amounted to € -1.3 million in the first half of 2025 (previous year: € 1.2 million), with the gross margin at 31.9%, on par with the previous year's level of 31.8%. The currently low utilization of production capacities is having a dampening effect on earnings – a significant improvement is expected in the further course of the year.

Against the backdrop of geopolitical turmoil, order intake in the first half of the year amounted to only € 21.1 million (previous year: € 52.3 million). In the second quarter of 2025, order intake was € 14.7 million (previous year: € 19.1 million).

The order backlog as of June 30, 2025, amounted to € 67.2 million, slightly below the previous year's level (€ 70.4 million). Unrestricted cash and cash equivalents amounted to € 5.9 million as of June 30, 2025, compared with € 11.3 million as of December 31, 2024.

SINGULUS TECHNOLOGIES continuously reviews the status of negotiations for new orders, the project progress of existing orders, and the global

macroeconomic development with regards to the forecast for business year 2025. For the second half of the year, SINGULUS TECHNOLOGIES expects a significant increase in sales and earnings, driven by upcoming shipments, rising capacity utilization, and new orders.

The company is currently facing an increasingly volatile global economic situation. In particular, the unclear development of international customs and trade policy – for example, between the US, China, and Europe – is causing uncertainty for the global flow of goods. Such conditions can significantly influence the timing and implementation of important solar projects, especially in the US market. Here, our customers' assessment of the new US government legislation ("One Big Beautiful Bill") will play a decisive role in the further implementation of the projects currently in planning. To counter these risks, SINGULUS TECHNOLOGIES is relying on a flexible production and supply chain strategy to cushion potential impacts and strengthen the company's resilience. Nevertheless, these could have a dampening effect on our company's business outlook for the rest of the fiscal year.

Technological expertise, coupled with innovative strength and a consistent focus on future markets, forms the foundation for positive development – even in a challenging geopolitical and economic environment.

The current assumptions and plans are based on the Executive Board's current assessment of the further development of the economic situation. However, due to the external factors mentioned above, future developments may differ from the current forecasts.

SEGMENTS

Semiconductor Segment – Technology Platform for Tomorrow's Semiconductor Applications

In addition to established customer projects, the positive business trend for semiconductor projects continues and interest in innovative process and equipment solutions from SINGULUS TECHNOLOGIES remains high. Promising discussions with potential new customers are opening up further project opportunities in a highly dynamic market. Thanks to the technological capabilities of the TIMARIS platform and its ability to flexibly map customer-specific process chains, SINGULUS TECHNOLOGIES is well positioned to successfully address this demand.

SINGULUS TECHNOLOGIES develops and supplies high-precision vacuum process systems for demanding applications in semiconductor, sensor, and thin-film technology. The focus is on the modular TIMARIS cluster platform, which is designed for the precise deposition of metallic, semiconducting, and dielectric layers below one nanometer. The platform meets the highest requirements for layer purity, layer homogeneity, reproducibility, and scalability – essential criteria for the production of complex, multi-layer coating systems.

The core of the technology is the integration of specialized process modules – including various sputtering and plasma systems – in an ultra-high vacuum (UHV) environment. This allows even the most demanding stack architectures to be realized

TIMARIS STM – Innovative vacuum deposition system for semiconductors and magnetic layers

without interrupting the vacuum, which is particularly important for modern spintronics and MRAM applications.

The systems are used worldwide by leading manufacturers – including for magnetoresistive sensors, inductors, and components for automotive, industrial, and communications electronics. Particularly high demand is evident in dynamically growing application fields such as magnetoresistive random access memory (MRAM), micro-LEDs, high-frequency power components, and CMOScompatible magnetics. SINGULUS TECHNOLOGIES' TIMARIS systems enable high-precision, efficient, and reproducible manufacturing in these areas – even for future packaging concepts such as heterogeneous integration and 3D structures.

Life Science Segment – Surface Technologies for Future Markets

The Executive Board sees opportunities for the positive development of recent years to continue in the Life Science segment. SINGULUS TECHNOLOGIES expects further order intake in this segment in the second half of the year.

Particularly promising prospects exist with existing customers for systems for the manufacture and finishing of contact lenses, thanks to the technological performance and regulatory compliance of the MEDLINE platform in daily production. However, new projects are also expected to be concluded in the Decorative Coating segment with the POLYCOATER and DECOLINE II product lines, which should contribute to order intake in the second half of the year.

The Medical Technology segment focuses on wet-chemical processes and vacuum-based coating technologies for medical applications. The MEDLINE platform was developed in collaboration with leading manufacturers and now offers a validated, GMP- and GxP-compliant solution for the industrial production and surface treatment of contact lenses. Process times have been significantly reduced and additional applications evaluated. The modular system concept allows the company to respond flexibly to individual customer requirements while meeting the high regulatory requirements of the international medical technology market. At the same time, further areas of application for the platform in medical and pharmaceutical technology are being investigated with the aim of substantially expanding the addressable market potential.

The second focus is on environmentally sustainable coating solutions for decorative applications, particularly in the cosmetics and automotive industries. With its POLYCOATER and DECOLINE II system solutions, SINGULUS TECHNOLOGIES offers modern, automated systems for surface finishing based on environmentally friendly, chromium(VI)-free processes. The high design flexibility and modularity of the platforms enable precise adaptation to changing market requirements, both in technical and economic terms. In an increasingly regulated and sustainabilityfocused environment, the company offers its customers future-proof and resource-saving technologies.

With its clear focus on high-margin, growing markets and regulatory-intensive industries, SINGULUS TECHNOLOGIES is strategically well positioned to generate profitable growth in the Life Science segment in the future.

SINGULUS TECHNOLOGIES presents its range of systems for the production of high-performance solar cells at Intersolar Europe

Solar Segment – Future Technologies for the Next Generation of Highly Efficient Solar Cells

SINGULUS TECHNOLOGIES has invested specifically in the further development and industrialization of innovative manufacturing processes for highperformance solar cells. The focus is on heterojunction cells (HJT) as well as perovskite and tandem technologies, which have the potential to establish new efficiency standards in photovoltaics – with efficiencies significantly above 30%. The continuous optimization of process technologies and close cooperation with industry and research partners are driving the series production of these cell architectures forward. Perovskite and tandem technologies remain a particularly exciting field for the future. SINGULUS TECHNOLOGIES will deliver several coating systems for these new applications in the current fiscal year. These developments underscore the company's technological leadership in a new market environment with growth potential.

At the same time, the market in Europe remains challenging. Although the political discussion about setting up solar cell production in Europe is continuing, concrete implementation has not yet taken place. New projects continue to be delayed. Realistic project opportunities exist in the US, but repeated changes in customs announcements and regulatory uncertainties based on new legislation could significantly hamper ongoing project execution. Regardless of federal legislation, however, individual states appear to be continuing to pursue their solar projects. SINGULUS TECHNOLOGIES therefore sees positive signs that it will be able to successfully complete a concrete project in the second half of the year.

SINGULUS TECHNOLOGIES offers turn-key production solutions for the industrial manufacturing of solar cells and modules. These integrate proven and forward-looking processes and equipment technologies, including PVD sputtering, PECVD

(Plasma Enhanced Chemical Vapor Deposition) and wet-chemical processes. The comprehensive service package comprising process technology, mechanical engineering, and digital factory management enables customers to achieve high production efficiency, low operating costs, and maximum plant availability.

In addition, thin-film solar technology – especially based on CIGS and CdTe – remains a strategically important part of the portfolio. These technologies continue to offer relevant applications in specific market segments and regional applications. Here, too, the new perovskite and tandem technology offers the possibility of significantly increasing the performance of the modules.

With a clear focus on technological excellence, sustainable production, and strategic partnerships, SINGULUS TECHNOLOGIES is positioning itself as a reliable system and innovation partner for the global expansion of photovoltaics.

New Business Areas with Strategic Prospects

With hydrogen technology and the industrial production of innovative battery solutions, SINGULUS TECHNOLOGIES is tapping into two important areas of the energy transition. Both business areas offer significant market potential, are technologically complementary to the company's existing expertise, and are based on clear industrial requirements. Initial orders in both segments confirm market validation and open up additional growth prospects outside the traditional core business.

Hydrogen Technology – Technological Contribution to Scaling a CO2 -free Energy Future

In the hydrogen sector, SINGULUS TECHNOLOGIES focuses on the development of manufacturing technologies for key components in fuel cells and

electrolyzers. The company addresses the increasing requirements for electrical conductivity, corrosion protection, and production speed through the targeted use of vacuum deposition and wet-chemical processes. A first order for a vacuum deposition system was received in the current fiscal year.

The solutions are designed for integration into scalable industrial manufacturing processes, thereby helping to reduce manufacturing costs and increase the market readiness of hydrogen technologies. The company is thus positioning itself as a potential partner for system providers and component manufacturers in a dynamically developing growth market.

Solid-state and Next-generation Batteries – New Production Solutions for the Energy Storage of Tomorrow

SINGULUS TECHNOLOGIES develops scalable production solutions for the industrial manufacturing of the next generation of batteries. The focus is on forward-looking cell technologies such as solid-state batteries, lithium-metal systems, and batteries with silicon anodes, which offer significant advantages over today's lithium-ion batteries: up to 30% higher energy density, a significantly longer service life, shorter charging times, and an improved safety profile through the use of solid electrolytes. These developments mark the beginning of a new era of energy storage in which innovative materials and precise process technologies play a central role.

SINGULUS TECHNOLOGIES is leveraging its comprehensive expertise in surface processing and coating technology to address the technical challenges of this new cell generation – particularly with regard to interface stability, the integration of functional material layers, and the scalability of manufacturing processes. Established processes

such as vacuum coating, thermal processes, and advanced sintering technologies are used, which have already been successfully applied in other high-tech markets.

In close cooperation with research institutions and pilot customers, the company is working on industrially applicable platform solutions that will also meet the requirements of future gigafactory standards in the medium term. The aim is to enable the economical series production of new battery concepts and to actively accelerate the market introduction of these technologies.

Strategic Added Value – Technology Transfer to High-growth Markets

The expansion into these two future-oriented fields follows a clear strategic logic: SINGULUS TECHNOLOGIES is leveraging its decades of experience in precision coating and process integration to transfer established expertise to new industrial applications. This creates technological synergies that enable rapid market introduction and efficiently complement the existing platform architecture.

The company is continuously evaluating further application fields in order to expand its position in rapidly growing technology markets and tap into new sources of revenue in the long term.

KEY FINANCIAL FIGURES

Order Intake and Order Backlog

Order intake in the reporting period reached € 21.1 million. Order intake in the same period of 2024 was € 52.3 million. In the second quarter, order intake amounted to € 14.7 million (previous year: € 19.1 million). The order backlog as of June 30, 2025, was € 67.2 million (previous year: € 70.4 million).

Revenue and Earnings

Revenue for the first six months of fiscal year 2025 was € 31.3 million, down from € 40.7 million in the previous year. The company expects capacity utilization to increase further in the coming quarters. In detail, revenue in the first half of 2025 was distributed across the Solar segment with € 9.0 million (previous year: € 24.0 million), Life Science with € 10.2 million (previous year: € 11.1 million) and Semiconductors with € 12.1 million (previous year: € 5.6 million). In the quarter under review, revenue

		Segment Solar		Segment Life Science		Segment Semiconductor		SINGULUS TECHNOLOGIES Group
Segment reporting from January 1 to June 30, 2025 and 2024	2025 million €	2024 million €	2025 million €	2024 million €	2025 million €	2024 million €	2025 million €	2024 million €
6-month figures Sales (gross)	9.0	24.0	10.2	11.1	12.1	5.6	31.3	40.7
Sales deduction and individual selling expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Sales (net)	9.0	24.0	10.2	11.1	12.1	5.6	31.3	40.7
Write-offs and amortization	-0.7	-0.8	-0.2	-0.4	-0.2	-0.1	-1.1	-1.3
Operating result (EBIT)	-2.7	1.7	-0.7	-0.6	2.1	0.1	-1.3	1.2
Financial result							-0.9	-1.5
Earnings before taxes							-2.2	-0.3
2nd Quarter Sales (gross)	5.3	12.3	6.0	4.1	3.6	3.7	14.9	20.1
Sales deduction and individual selling expenses	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1
Sales (net)	5.3	12.4	6.0	4.1	3.6	3.7	14.9	20.2
Write-offs and amortization	-0.4	-0.4	-0.1	-0.2	-0.1	-0.1	-0.6	-0.7
Operating result (EBIT)	-2.3	1.6	0.4	-1.5	0.1	0.4	-1.9	0.5
Financial result							-0.2	-0.7
Earnings before taxes							-2.1	-0.2

amounted to € 5.3 million in the Solar segment (previous year: € 12.3 million), € 6.0 million in the Life Science segment (previous year: € 4.1 million) and € 3.6 million in the Semiconductor segment (previous year: € 3.7 million).

For the first half of 2025, the regional breakdown of sales in percentage terms is as follows: Europe 37.4% (previous year: 26.1%), Asia 45.0% (previous year: 60.4%), North and South America 17.6% (previous year: 3.0%) and Africa and Australia 0.0% (previous year: 0.0%). The regional distribution of sales in percentage terms for the second quarter of 2025 is as follows: Asia 44.6% (previous year: 60.4%), Europe 35.6% (previous year: 26.1%), North and South America 19.8% (previous year: 13.5%) and Africa and Australia 0.0% (previous year: 0.0%).

In the first half of 2025, the gross margin remained at the previous year's level at 31.9% (previous year: 31.8%). In the second quarter of 2025, the gross margin decreased to 29.1% (previous year: 33.8%).

Operating expenses for the first half of 2025 amounted to € 11.3 million, down on the previous year's figure (€ 11.7 million).

In the quarter under review, expenses for research and development amounted to € 1.2 million (previous year: € 1.7 million), for sales and customer service € 2.8 million (previous year: € 2.7 million) and for general administration € 2.1 million (previous year: € 2.0 million). Other operating expenses amounted to € 0.5 million (previous year: € 0.0 million), while other operating income amounted to € 0.5 million (previous year: € 0.1 million).

Overall, the first half of 2025 closed with negative earnings before interest and taxes (EBIT) of € -1.3 million (previous year: € 1.2 million). In the second quarter of 2025, EBIT amounted to € -1.8 million (previous year: € 0.5 million).

Balance Sheet and Liquidity

Current assets amounted to € 39.1 million in the reporting period, down on the previous year's figure (December 31, 2024: € 39.4 million). This is mainly due to the decline in cash and cash equivalents (€ -5.4 million) and raw materials and consumables (€ -1.3 million) in connection with the processing of current customer orders. The company expects significant payments from customers in the coming months in connection with the underlying projects.

As of June 30, 2025, non-current assets amounted to € 18.8 million, slightly below the previous year's figure (December 31, 2024: € 19.1 million).

Current liabilities increased slightly compared to the end of 2024 and amounted to € 80.6 million as of June 30, 2025 (December 31, 2024: € 79.9 million), mainly due to the increase in liabilities from construction contracts (+ € 4.9 million) in connection with the processing of ongoing projects.

As of June 30, 2025, long-term liabilities amounted to € 29.0 million, roughly on par with the same period of the previous year (December 31, 2024: € 28.6 million).

Equity

The Group's equity as of June 30, 2025, amounted to € -51.7 million, which is attributable in full to the shareholders of the parent company (December 31, 2024: € -50.0 million). However, the company expects its equity position to improve significantly in the coming years.

Cash Flow

In the first half of 2025, the Group's operating cash flow was negative at € -1.4 million (previous year: € -7.6 million). This is mainly attributable to the completion of customer projects for which advance payments were made in previous periods. Cash flow from investing activities amounted to € -0.7 million (previous year: € -1.2 million). Cash flow from financing activities amounted to € -3.4 million in the reporting period (previous year: € 2.5 million). Overall, cash and cash equivalents decreased by € 5.4 million to € 5.9 million in the first half of 2025 (December 31, 2024: € 11.3 million).

RISK REPORT

Summary of Risks

As an internationally active company, SINGULUS TECHNOLOGIES continuously monitors economic and political developments in its main sales markets. Global uncertainties – such as geopolitical tensions, supply chain problems or an intensified international trade conflict – can have a significant impact on sales, production, purchasing and logistics.

Particular attention is currently being paid to the customs dispute between the US, China, and Europe. Even the agreement between Europe and the

US does not eliminate these uncertainties. Further escalation could lead to additional import duties worldwide, which could have a negative impact on orders placed by our customers and result in delays in customs clearance and increased regulatory requirements. This could potentially have a negative impact on our order situation, procurement processes, cost structures, and international project management, particularly with regard to time-critical delivery volumes and competitiveness vis-à-vis local suppliers. Price increases for raw materials and energy are not currently having a significant impact, as purchase prices are fixed for ongoing projects. Material price increases can be passed on to a large extent in new contracts.

All identified risk areas are presented in detail in the 2024 Annual Report. In addition, risks that are currently unknown or considered immaterial could also affect the financial position and results of operations. For example, declining consumer confidence in our customers' key sales markets could lead to investment decisions in new machinery and equipment being postponed. This could result in considerable uncertainty regarding the Company's future economic development.

Sales Market Risk

The company is generally subject to global economic cycles and geopolitical risks that can have a negative impact on its business. SINGULUS TECHNOLOGIES is particularly dependent on its international customers' willingness to invest in new production facilities. Slumps in demand or misjudgments regarding the development of markets and products can have a negative impact on the company's results.

Due to the high importance of this business segment, the market risk in the Solar segment is rated with a relevance indicator of 5 (December 31, 2024: 5). Management expects high sales revenues in the Solar segment over the coming years. Despite the entry into new business areas, this segment is expected to continue to contribute the largest share of sales and earnings in the current fiscal year. Due to the significant decline in orders in previous years and the ongoing delays in the conclusion of contracts for current projects, the probability of occurrence was assessed as high (December 31, 2024: high) and the relevance as a threat to the company's continued existence.

In addition to the core Solar segment, the Life Science segment will be of great importance for further business development in the coming years. The company expects a steady expansion of business activities in this area. However, there is a high degree of dependence on specific investment cycles in production facilities of a few globally active customers. Furthermore, the company has so far been mainly active in the field of contact lenses in the medical technology sector.

The Semiconductor segment will also become increasingly important for further business development in the coming years. The company expects a significant expansion of business activities in this area. A significant increase in sales revenues was already recorded in the reporting year in connection with a considerable increase in demand for semiconductor equipment for various applications from China. The company anticipates a further positive development in this region in the coming years.

Financial Risks

We currently assign a relevance rating of 5 to liquidity risk and a relevance rating of 3 to default risk.

Despite receiving further partial payments from customer projects and taking out loans, we continue to assess the probability of liquidity risk as very high. Liquidity is a key area of risk. Project delays, late advance payments or bad debts can cause short-term bottlenecks. Many projects require surety bonds, for which cash and cash equivalents must be deposited as collateral, meaning that these are then not available as working capital.

Since the company has virtually no access to debt capital for financing, the development of freely available cash and cash equivalents for 2025 and 2026 depends to a large extent on whether new orders currently under negotiation are actually awarded to the company and whether the resulting payments are received by SINGULUS TECHNOLOGIES as planned and in a timely manner.

The Group relies on regular liquidity planning, credit insurance, and ongoing credit checks of customers to closely monitor its available liquidity. Discussions are currently underway regarding new guarantee facilities with reduced collateral requirements in order to increase financial flexibility.

Furthermore, in connection with the company's refinancing, we refer to the explanations in the section "Financing of the Company" and the presentation of financial risks in the risk report of the 2024 Annual Report.

The events and circumstances described here indicate the existence of a significant uncertainty that could raise significant doubts about the ability of the company and the Group to continue as a going concern and that constitute a risk to the company's continued existence within the meaning of Section 322 (2) sentence 3 of the German Commercial Code (HGB). The SINGULUS TECHNOLOGIES Group may therefore not be able to meet its payment obligations in the normal course of business, realize its assets, and settle its liabilities.

Project Risks

If risks in connection with order processing materialize, these could have a significant negative impact on business activities, particularly in connection with the implementation of larger projects. The risk of missing project deadlines or planned costs and the failure to meet acceptance criteria are considered to be particularly significant. In particular, the scheduled order processing of our large-scale projects is of great importance for the continued existence of the company and the Group. Should these projects fail in whole or in part, or should the planned economic success not be sufficiently realized, this could have a significant negative impact on the company's net assets, financial position, and results of operations, and could even jeopardize the company's existence. In summary, we continue to assess the project risks with a relevance indicator of 5 (December 31, 2024: 5). The probability of occurrence is classified as medium (December 31, 2024: medium).

DEVELOPMENT OF COSTS AND PRICES

In our view, sales prices developed as planned in the reporting period. Purchasing prices and, as a result, material expenses also developed in line with our expectations. In general, it is difficult to predict how purchase prices and sales prices will develop due to various uncertainties and global unrest in different parts of the world. The majority of purchase prices for ongoing customer projects have already been fixed, and in current customer negotiations, potential increases in material prices can largely be passed on to contractual partners. To date, there have been no significant negative effects on the company's main sales markets of the company.

FINANCING OF THE COMPANY

The company currently has the following sources of financing available. The corporate bond issued by the company with a nominal volume of € 12.0 million has a term until July 22, 2026 and an interest rate of 4.5%. The repayment amount is 105.0%. The increased repayment amount also applies in the event of early repayment. The Executive Board plans to repay the bond at maturity from operating cash flow or to transfer it to new financing. If sufficient refinancing of the bond cannot be secured in good time before its final maturity, the Company's continued existence would be at risk.

A loan from the Bank of Shanghai, Hong Kong, in the amount of approximately € 9.0 million (i.e., RMB 74.0 million) has been available to SINGULUS TECHNOLOGIES since April 2025 to secure liquidity. Repayment of the loan is guaranteed by the Chinese majority shareholder Triumph Science & Technologies Co. Ltd., Beijing/China, (Triumph), a subgroup of China National Building Material Group Corporation, Beijing/China, (CNBM). The term of the loan is twelve months with maturity on April 8, 2026.

To bridge short-term liquidity bottlenecks, Triumph International Investment Company Limited, Hong Kong/China (CTIIC), a subsidiary of the main shareholder Triumph, granted the company shortterm financing in the amount of € 6.0 million (CTIIC financing) with effect from August 19, 2024. This has been drawn down in full and is available until September 30, 2025.

In addition, the company has access to a senior secured loan ("Super Senior Loan") in the amount of € 4.0 million. The company drew down the first tranche of € 2.0 million in May 2023 and the second tranche of € 2.0 million in January 2024. The current term of the loan tranches is until March 31, 2026.

Furthermore, at the end of the 2024 fiscal year, a lender granted the Company unsecured working capital financing of an additional € 2.0 million, which was initially due for repayment on March 31, 2025. The Executive Board has extended the term of this loan with the lender until March 31, 2026.

The company refers to the comments and classifications regarding financial risks in this quarterly report and to the detailed descriptions in the annual report for the year 2024.

RESEARCH AND DEVELOPMENT

At € 2.3 million in the first half of 2025, research and development expenditure was below the level of the first half of 2024 (€ 2.6 million). In the reporting quarter, expenditure on development services amounted to € 1.2 million (first half of 2024: € 1.7 million).

EMPLOYEES

The number of employees in the SINGULUS TECHNOLOGIES Group remained stable at 288 as of June 30, 2025 (December 31, 2024: 289 employees).

SINGULUS TECHNOLOGIES SHARE

The share price of SINGULUS TECHNOLOGIES was € 2.00 at the beginning of the second quarter and closed slightly weaker at € 1.89 on June 30, 2025. Since then, the price has fluctuated below the € 2 mark and stands at € 1.77 at the time of going to press. SINGULUS TECHNOLOGIES currently has a free float of around 72.47%.

ANNUAL GENERAL MEETING ON MAY 21, 2025

At the Annual General Meeting of SINGULUS TECHNOLOGIES AG on May 21, 2025, in Frankfurt am Main, 28.0% of the voting share capital was represented. All items on the agenda were approved with the required majorities.

Dr. Wolfhard Leichnitz resigned from the Supervisory Board after many years of dedicated service. The Annual General Meeting elected Mr. Frank Averdung as a new member of the Supervisory Board with 99.9% of the votes cast. In the constituent meeting held following the Annual Shareholders' Meeting, the previous Deputy Chairman of the Supervisory Board, Mr. Changfeng Tu, was elected Chairman of the Supervisory Board.

The Executive Board of SINGULUS TECHNOLOGIES would like to thank Dr. Leichnitz for his many years of commitment, his entrepreneurial vision and the consistently trusting cooperation. Dr. Leichnitz has played a key role in the development of the company over many years and provided valuable impetus.

With Mr. Averdung, SINGULUS TECHNOLOGIES has succeeded in gaining a proven expert for the Supervisory Board who is well versed in the key industries in which the company operates. With his extensive management experience in international high-tech companies and his expertise in the key markets for semiconductors and solar, he will help the Executive Board to decisively advance the strategic development of SINGULUS TECHNOLOGIES. The Executive Board looks forward to working with Mr. Averdung in the future.

ANNUAL FINANCIAL STATEMENTS FOR 2024 PUBLISHED ON SCHEDULE

The company's annual financial statements for the 2024 fiscal year were audited by the auditors appointed by the Annual Shareholders' Meeting and issued with an unqualified audit opinion. The Supervisory Board of SINGULUS TECHNOLOGIES approved the annual financial statements, the consolidated financial statements and the combined management report of the company for the fiscal year 2024 on March 25, 2025, and adopted the annual financial statements. The 2024 annual financial statements were published on March 28, 2025, on the company's website at: https:// www.singulus.com/financial-reports/. The audited ESEF versions were published in the Federal Gazette and via the ERS system of Deutsche Börse on schedule at the end of April.

Yours sincerely

The Executive Board

SINGULUS TECHNOLOGIES AG

SINGULUS TECHNOLOGIES GROUP BALANCE SHEET

as of June 30, 2025 and December 31, 2024

	June 30, 2025	Dec. 31, 2024
ASSETS	[million €]	[million €]
Cash and cash equivalents	5.9	11.3
Restricted cash	3.2	1.3
Trade receivables	2.8	4.1
Receivables from construction contracts	12.6	10.2
Borrowings	0.0	0.0
Other receivables and other assets	6.7	6.3
Total receivables and other assets	22.1	20.6
Raw materials, consumables and supplies	3.4	4.7
Work in process	4.5	1.5
Total inventories	7.9	6.2
Total current assets	39.1	39.4
Trade receivables	0.0	0.0
Borrowings	0.0	0.0
Property, plant and equipment	5.8	6.4
Investment property	0.0	0.0
Capitalized development costs	5.7	5.3
Goodwill	6.7	6.7
Other intangible assets	0.4	0.5
Deferred tax assets	0.2	0.2
Total non-current assets	18.8	19.1
Non-current assets held for sale	0.0	0.0

Total assets	57.9	58.5

	June 30, 2025	Dec. 31, 2024
EQUITY AND LIABILITIES	[million €]	[million €]
Trade payables	11.4	14.1
Prepayments received	2.1	3.2
Liabilities from construction contracts	32.5	27.6
Financing liabilities from the issuance of loans and other financing liabilities	21.1	22.1
Financing liabilities from the issuance of bonds	0.2	0.2
Current leasing liabilities	0.8	0.7
Other current liabilities	9.1	7.6
Provisions for restructuring measures	0.1	0.1
Provisions for taxes	0.6	0.6
Other provisions	2.7	3.7
Total current liabilities	80.6	79.9
Financing liabilities from the issuance of bonds	12.0	11.8
Financing liabilities from the issuance of loans	0.0	0.0
Other non-current liabilities	0.0	0.0
Non-current leasing liabilities	0.2	0.0
Provisions for restructuring measures	0.0	0.0
Pension provisions	11.9	11.9
Deferred tax liabilities	4.9	4.9
Total non-current liabilities	29.0	28.6
Debt related to non-current assets held for sale	0.0	0.0
Total liabilities	109.6	108.5
Subscribed capital	8.3	8.9
Capital reserves	19.3	19.8
Other reserves	0.9	1.8
Retained earnings	-80.2	-80.5
Equity attributable to owners of the parent	-51.7	-50.0
Non-controlling interests	0.0	0.0
Total equity	-51.7	-50.0
Total equity and liabilities	57.9	58.5

SINGULUS TECHNOLOGIES GROUP INCOME STATEMENT

from January 1 to June 30, 2025 and 2024

		2nd Quarter 2025		2nd Quarter 2024		Jan. 1 - June 30, 2025		Jan. 1 - June 30, 2024
	[million €]	[%]	[million €]	[%]	[million €]	[%]	[million €]	[%]
Revenue (gross)	14.9	100.0	20.1	100.0	31.3	100.0	40.7	100.2
Sales deductions and direct selling costs	0.0	0.0	0.0	0.0	0.0	0.0	-0.1	-0.2
Revenue (net)	14.9	100.0	20.1	100.0	31.3	100.0	40.6	100.0
Cost of sales	-10.5	-70.9	-13.3	-66.2	-21.3	-68.1	-27.7	-68.2
Gross profit on sales	4.3	29.1	6.8	33.8	10.0	31.9	12.9	31.8
Research and development	-1.2	-8.2	-1.7	-8.5	-2.3	-7.3	-2.6	-6.4
Sales and customer service	-2.8	-18.8	-2.7	-13.4	-5.4	-17.3	-5.5	-13.5
General administration	-2.1	-14.1	-2.0	-10.0	-3.9	-12.5	-3.8	-9.4
Other operating expenses	-0.5	-3.4	0.0	0.0	-0.7	-2.2	-0.1	-0.2
Other operating income	0.5	3.4	0.1	0.5	1.0	3.2	0.3	0.7
Total operating expenses	-6.1	-41.1	-6.3	-31.3	-11.3	-36.1	-11.7	-28.8
Operating result (EBIT)	-1.8	-12.0	0.5	2.5	-1.3	-4.2	1.2	3.0
Finance income	0.1	0.7	0.0	0.0	0.1	0.3	0.0	0.0
Finance costs	-0.2	-1.3	-0.7	-3.5	-1.0	-3.2	-1.5	-3.7
EBT	-1.9	-12.7	-0.2	-1.0	-2.2	-7.0	-0.3	-0.7
Tax expense/income	0.1	0.7	0.0	0.0	0.1	0.3	0.1	0.2
Profit or loss for the period	-1.8	-12.0	-0.2	-1.0	-2.1	-6.7	-0.2	-0.5
Thereof attributable to:
Owners of the parent	-1.8		-0.2		-2.1		-0.2
Non-controlling interests	0.0		0.0		0.0		0.0
	[€]		[€]		[€]		[€]
Basic earnings per share based on the profit for the period (in EUR) attributable to owners of the parent	-0.20		-0.02		-0.24		-0.02
Diluted earnings per share based on the profit for the period (in EUR) attributable to owners of the parent	-0.20		-0.02		-0.24		-0.02

SINGULUS TECHNOLOGIES GROUP STATEMENT OF COMPREHENSIVE INCOME

from January 1 to June 30, 2025 and 2024

	2nd Quarter 2025 [million €]	2nd Quarter 2024 [million €]	Jan. 1 - June 30, 2025 [million €]	Jan. 1 - June 30, 2024 [million €]
Profit or loss for the period	-1.8	-0.2	-2.1	-0.2
Items that will be reclassifiedto profit and loss:
Exchange differences in the fiscal year	0.2	0.0	0.4	0.0
Total income and expense recognized directly in other comprehensive income	0.2	0.0	0.4	0.0
Total comprehensive income	-1.6	-0.2	-1.7	-0.2
Thereof attributable to:
Owners of the parent	-1.6	-0.2	-1.7	-0.2

SINGULUS TECHNOLOGIES GROUP STATEMENT OF CHANGES IN EQUITY

as of June 30, 2025 and 2024

		Equity Attributable to Owners of the Parent
	Subscribed Capital	Capital Reserves	Other Reserves
	[million €]	[million €]	Currency Translation Reserves [million €]
As of January 1, 2024	8.9	19.8	4.8
Profit or loss for the period	0.0	0.0	0.0
Other comprehensive income	0.0	0.0	-0.1
Total comprehensive income	0.0	0.0	-0.1
As of June 30, 2024	8.9	19.8	4.7
As of January 1, 2025	8.9	19.8	4.7
Profit or loss for the period	0.0	0.0	0.0
Other comprehensive income	0.0	0.0	0.4
Total comprehensive income	0.0	0.0	0.4
As of June 30, 2025	8.9	19.8	5.1

Equity	Non-controlling interests		Equity Attributable to Owners of the Parent
		Total	Retained Earnings	Other Reserves
[million €]	[million €]	[million €]	Other Retained Reserves [million €]	Actual Gains and Losses from Pension Commitments [million €]
-44.6	0.0	-44.6	-75.1	-3.0
-5.4	0.0	-5.4	-5.4	0.0
0.0	0.0	0.0	0.0	0.1
-5.4	0.0	-5.4	-5.4	0.1
-50.0	0.0	-50.0	-80.5	-2.9
-50.0	0.0	-50.0	-80.5	-2.9
-2.1	0.0	-2.1	-2.1	0.0
0.4	0.0	0.4	0.0	0.0
-1.7	0.0	-1.7	-2.1	0.0
-51.7	0.0	-51.7	-82.6	-2.9

SINGULUS TECHNOLOGIES GROUP STATEMENT OF CASH FLOWS

from January 1 to June 30, 2025 and 2024

	Jan. 1 - June 30, 2025 [million €]	Jan. 1 - June 30, 2024 [million €]
Cash flows from operating activities
Profit or loss for the period	-2.1	-0.2
Adjustment to reconcile profit or loss for the period to net cash flow
Amortization, depreciation and impairment of non-current assets	1.1	1.3
Contribution to the pension provisions	0.3	0.3
Profit/loss from disposal of non-current assets	0.0	0.0
Other non-cash expenses/income	0.0	0.0
Net finance costs	0.9	1.5
Net tax expense	-0.1	-0.1
Change in trade receivables	1.3	0.6
Change in construction contracts	2.5	-9.9
Change in other receivables and other assets	-0.4	-1.7
Change in inventories	-1.7	2.7
Change in trade payables	-2.7	4.0
Change in other liabilities	1.5	-3.4
Change in prepayments	-1.1	0.0
Change in provisions from restructuring measures	0.0	-0.1
Change in further provisions	-1.0	-2.6
Interest paid	0.0	0.0
Tax paid	0.1	0.0
	0.7	-7.4
Net cash from/used in operating activities	-1.4	-7.6

	Jan. 1 - Jan. 1 - June 30, 2025 June 30, 2024 [million €] [million €]
Cash flows from investing activities
Cash paid for investments in development projects	-0.6	-0.7
Cash paid for investments in other intangible assets and property, plant and equipment	-0.1	-0.5
Proceeds from the sale of assets and liabilities classified as held for sale	0.0	0.0
Net cash from/used in investing activities	-0.7	-1.2
Cash flows from financing activities
Auszahlungen für Anleihezinsen	-0.3	-0.3
Cash received/used on the issuance of loans and other financing commitments	-1.0	2.0
Cash used to pay loan interest	-0.2	-0.3
Cash used to pay leasing liabilities	0.0	-0.2
Cash received/used on financial assets subject to restrictions on disposal	-1.9	1.3
Net cash from/used in financing activities	-3.4	2.5
Increase/decrease in cash and cash equivalents	-5.5	-6.3
Effect of exchange rate changes	-0.1	-0.1
Cash and cash equivalents at the beginning of the reporting period	11.5	11.5
Cash and cash equivalents at the end of the reporting period	5.9	5.1

Cash and cash equivalents comprise monetary investments with a remaining maturity of up to three months at the time of acquisition.

Financial assets subject to restrictions on disposal are presented separately in the balance sheet. These financial assets relate to the Company's financing transactions and are included in the consolidated cash flow statement as cash flows from financing activities.

ANNOTATIONS TO THE INTERIM FINANCIAL STATEMENTS

SINGULUS TECHNOLOGIES Aktiengesellschaft (hereinafter also referred to as "SINGULUS" or "Company") is a publicly traded corporation with its registered office in Germany. The present consolidated financial statements for the interim reporting of SINGULUS TECHNOLOGIES AG and its subsidiaries ("Group") for the first six months of fiscal year 2025 were approved for publication by resolution of the Executive Board on August 12, 2025.

The consolidated financial statements are drawn up in Euros (€). Unless otherwise stated, all amounts are in millions of Euros (€ million). Rounding differences may arise from the use of € million.

Accounting and Valuation Principles

The condensed interim consolidated financial statements for the period from January 1, 2025, to June 30, 2025, were prepared in accordance with IAS 34 "Interim Financial Reporting." The interim financial statements have not been audited or reviewed.

Half of the share capital according to HGB was used up in the 2017 fiscal year and reported on September 21, 2017. An Extraordinary General Meeting was held on November 29, 2017. At the Extraordinary General Meeting on October 29, 2021, and at the subsequent Annual General Meetings in 2023, 2024, and 2025, the Executive Board reported on the loss of the parent company's share capital in accordance with HGB pursuant to Section 92 (1) AktG. The background to the erosion of equity was presented, which was mainly due to the timing differences in revenue recognition under HGB and IFRS and to operating losses resulting from underutilization of the organization in recent years.

However, from today's perspective, the company has sufficient freely available liquid funds to secure its business activities and therefore continues to operate on a going concern basis.

The SINGULUS TECHNOLOGIES Group is highly dependent on the future development of its business activities with a small number of large customers, both in terms of achieving the expected financial figures and the further development of liquidity. Sufficient liquidity of the company and the Group in the next 24 months after the end of fiscal year 2024 can only be maintained if the planning for this period can be realized. Essential prerequisites for this planning are that the partial payments to be made on the basis of the major orders already contracted are actually made or are not subject to material delays. In addition, it is necessary to secure further significant large orders by the end of 2026. Furthermore, the repayment or refinancing of significant components of borrowed capital must be ensured in the coming twelve months. During this period, the following loans will mature: the super senior loan in the amount of € 4.0 million in March 2026, the corporate bond issued by the company with a nominal volume of € 12.0 million and a maturity date of July 22, 2026, and a repayment amount of 105.0%, the working capital loan of EUR 2.0 million and the working capital facility from Bank of Shanghai, Hong Kong, with a volume of approximately € 9.0 million (RMB 74.0 million) and maturing in April 2026.

These events and circumstances indicate the existence of a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern and constitutes a risk to the Company's continued existence within the meaning of Section 322 (2) sentence 3 of the German Commercial Code (HGB).

The preparation of the interim financial statements in accordance with IAS 34 requires estimates and assumptions by management that affect the reported amounts of assets, liabilities, revenues, income, expenses, and contingent liabilities. These assumptions and estimates relate primarily to the Group-wide determination of economic useful lives, the impairment of assets, the measurement of provisions, the recoverability of receivables, the recognition of recoverable residual values in inventories, and the recoverability of future tax relief. The actual values may differ from the assumptions and estimates made in individual cases. Changes are recognized in profit or loss when they become known. The accounting policies applied in the interim consolidated financial statements are consistent with those applied in the last published consolidated financial statements for the 2024 fiscal year. A detailed description of the accounting principles is published in the notes to the consolidated financial statements in our 2024 annual report.

Consolidated

In addition to SINGULUS TECHNOLOGIES AG, the consolidated financial statements include all companies that are under the legal or de facto control of the company. In addition to SINGULUS TECHNOLOGIES AG, a total of two domestic and nine foreign subsidiaries were included in the interim financial statements as of June 30, 2025. No companies were included in the scope of consolidation during the reporting period, nor did any companies leave the scope of consolidation.

Trade Receivables and Receivables from Construction Contracts

Trade receivables and receivables from contract manufacturing are broken down as follows as of June 30, 2025:

	June 30, 2025 million €	June 30, 2024 million €
Accounts receivable – short-term	2.8	4.1
Receivables from construction contracts	12.7	10.3
Less allowances	-0.1	-0.1
	15.4	14.3

Intangible Assets

Intangible assets include capitalized development expenses, goodwill, customer bases, concessions, intellectual property rights, and other intangible assets. Capitalized development costs amounted to € 5.7 million as of June 30, 2025 (December 31, 2024: € 5.3 million). Investments in development totaled € 0.6 million in the first six months of 2025 (previous year: € 0.7 million). Scheduled amortization of capitalized development costs amounted to € 0.3 million (previous year: € 0.5 million). In the quarter under review, € 0.2 million (previous year: € 0.2 million) was invested in development activities, with scheduled amortization amounting to € 0.1 million (previous year: € 0.2 million).

Property, Plant, and Equipment

In the first half of fiscal year 2025, € 0.1 million was invested in property, plant, and equipment (previous year: € 0.5 million). Scheduled depreciation and amortization amounted to € 0.8 million in the same period (previous year: € 0.8 million). Scheduled depreciation and amortization for the reporting quarter amounted to € 0.4 million (previous year: € 0.4 million).

Breakdown of Sales

The following matrix allocates revenue for the reporting period to the individual segments according to selected categories.

JANUARY 1 TO JUNE 30, 2025	Solar million €	Life Science million €	Semiconductor million €	Total million €
Revenue by country of destination
Germany	1.5	1.3	0.1	2.9
Rest of Europe	3.1	5.6	0.2	8.9
North and South America	3.1	1.4	1.1	5.6
Asia	1.3	1.9	10.7	13.9
Africa & Australia	0.0	0.0	0.0	0.0
	9.0	10.2	12.1	31.3
Revenue by country of origin
Germany	8.3	6.8	9.6	24.7
Rest of Europe	0.0	0.2	0.1	0.3
North and South America	0.0	1.4	0.4	1.8
Asia	0.7	1.8	2.0	4.5
Africa & Australia	0.0	0.0	0.0	0.0
	9.0	10.2	12.1	31.3
Products and services
Production facilities	7.6	5.8	9.7	23.1
Service and spare parts	1.4	4.4	2.4	8.2
	9.0	10.2	12.1	31.3
Revenue recognition date
Periodic revenue recognition	7.6	5.8	9.7	23.1
Revenue recognition as of a specific date	1.4	4.4	2.4	8.2
	9.0	10.2	12.1	31.3

JANUARY 1 TO JUNE 30, 2024	Solar million €	Life Science million €	Semiconductor million €	Total million €
Revenue by country of destination
Germany	2.8	0.8	0.3	3.9
Rest of Europe	3.9	1.8	1.1	6.8
North and South America	2.6	1.9	1.0	5.5
Asia	14.7	6.6	3.2	24.5
Africa & Australia	0.0	0.0	0.0	0.0
	24.0	11.1	5.6	40.7
Revenue by country of origin
Germany	24.0	8.5	5.1	37.6
Rest of Europe	0.0	0.2	0.1	0.3
North and South America	0.0	1.0	0.3	1.3
Asia	0.0	1.4	0.1	1.5
Africa & Australia	0.0	0.0	0.0	0.0
	24.0	11.1	5.6	40.7
Products and services
Production facilities	21.2	7.7	5.0	33.9
Service and spare parts	2.8	3.4	0.6	6.8
	24.0	11.1	5.6	40.7
Revenue recognition date
Periodic revenue recognition	18.2	6.8	4.9	29.9
Revenue recognition as of a specific date	5.8	4.3	0.7	10.8
	24.0	11.1	5.6	40.7

Sales Deductions and Direct Selling Costs

Reductions in sales include discounts granted. Individual distribution costs mainly comprise expenses for packaging, freight and commissions.

General Administrative Expenses

Administrative expenses include expenses for management, human resources, finance, and accounting, as well as the associated office and vehicle costs. This item also includes

ongoing IT costs, legal and consulting fees, investor relations costs, costs for the Annual Shareholders' Meeting, and costs for the preparation of the annual financial statements.

Research and Development Expenses

In addition to research expenses and non-capitalizable development expenses, research and development expenses for the first half of 2025 continue to include scheduled amortization of capitalized development costs in the amount

of € 0.3 million (previous year: € 0.5 million). In the second quarter of 2025, amortization of capitalized development costs amounted to € 0.1 million (previous year: € 0.2 million).

Financial Instruments

The following table shows the carrying amounts and fair values of all financial instruments recognized in the consolidated financial statements by class.

	Valuation method	Carrying amount		Fair values
		June 30, 2025 million €	June 30, 2024 million €	June 30, 2025 million €	June 30, 2024 million €
Financial assets
Cash and cash equivalents **	AC	5.9	11.3	–	–
Restricted cash **	AC	3.2	1.3	–	–
Derivative financial instruments
Hedging derivative **	HD	–	–	–	–
Trade receivables **	AC	2.8	4.1	–	–
Other receivables	AC	6.7	6.3	–	–
Financial liabilities
Bond *	AC	12.2	12.0	9.0	7.6
Liabilities from loans	AC	21.1	22.1	–	–
Derivative financial instruments
Hedging derivative **	HD	–	–	–	–
Liabilities from deliveries and services **	AC	11.4	14.1	–	–
Other liabilities	AC	9.1	7.6	–	–
Liabilities related to non-current assets held for sale	AC	0.0	0.0	–	–
Total	AC	72.4	78.8	–	–
Total	HD	0.0	0.0	–	–

* The fair value measurement was classified as fair value of Level 1 based on the input factors of the measurement techniques used.

** The fair value measurements were classified as fair values of Level 2 based on the input factors of the valuation techniques used, as fair values at Level 2.

Abbreviations:

AC: Amortised cost (financial assets or liabilities measured at amortised cost) HD: Hedging derivatives

Cash and cash equivalents, restricted cash, and trade payables generally have short- e maturities. The amounts recognized in the balance sheet approximate fair value. The same applies to short-term trade receivables and other assets.

The fair values of non-current trade receivables correspond to the present values of the payments associated with the assets, taking into account the relevant interest rate parameters.

The valuation rates used for the forward exchange contracts concluded are the ECB reference rates for the spot currency and the valid forward valuation rates of the respective commercial bank for the forward currency.

The fair value of the listed bond corresponds to the market price on the balance sheet date plus the carrying amount of the deferred interest liabilities as of the balance sheet date.

The fair values of liabilities from loans correspond to the repayment amount of the loans on the balance sheet date.

The maximum credit risk is reflected in the carrying amounts of financial assets and liabilities.

Financial Income and Financing Expenses

Interest income/expenses are composed as follows:

	June 30, 2025 million €	June 30, 2024 million €
Financing expenses from issuance of bond	-0.3	-0.3
Interest expenses from the discounting of pension provisions	-0.2	-0.2
Financing expenses from loans	-0.2	-0.6
Other financing costs	-0.3	-0.3
	-1.0	-1.4

Earnings per Share

When calculating basic earnings per share, the earnings attributable to the holders of ordinary shares of the parent company are divided by the weighted average number of ordinary shares outstanding during the reporting period.

When calculating diluted earnings per share, the earnings attributable to the holders of ordinary shares of the parent company are divided by the weighted average number of ordinary shares outstanding during the reporting period plus the weighted average number of ordinary shares that would result from the conversion of all potential ordinary shares with a dilutive effect into ordinary shares. There were no dilutive effects in the reporting quarter or in the same period of the previous year. No transactions involving ordinary shares or potential ordinary shares took place between the balance sheet date and the preparation of the consolidated financial statements.

Financing Liabilities from the Bond Issue

The secured bond (ISIN DE000A2AA5H5) with a volume of € 12.0 million was issued in July 2016. The original term of five years was extended by an additional five years by resolution dated May 6, 2021. The nominal interest rate for the extended term is 4.5% p.a. The repayment amount per partial bond in the nominal amount of € 100.00 will be increased by € 5.00 to € 105.00. The effective interest rate for the additional five years is 5.4% p.a.

The bond is secured primarily by cash and cash equivalents, receivables, inventories, property, plant and equipment, and intangible assets of SINGULUS TECHNOLOGIES AG.

Financing Liabilities

The company currently has the following sources of financing available. The corporate bond issued by the company with a nominal volume of € 12.0 million has a term until July 22, 2026 and an interest rate of 4.5%. The repayment amount is 105.0%. The increased repayment amount also applies in the event of early repayment. The Executive Board plans to repay the bond at maturity from operating cash flow or to transfer it to a new financing arrangement, so that the risks associated with this remain in the realization of the plan.

A loan from the Bank of Shanghai, Hong Kong, in the amount of approximately € 9.0 million (RMB 74.0 million) has been available to SINGULUS TECHNOLOGIES since April 2025 to secure liquidity. The repayment of the loan is guaranteed by the Chinese majority shareholder Triumph Science & Technologies Co. Ltd., Beijing/China (Triumph), a subgroup

of China National Building Material Group Corporation, Beijing/China (CNBM). The term of the loan is twelve months with maturity on April 8, 2026.

To bridge short-term liquidity bottlenecks, Triumph International Investment Company Limited, Hong Kong/China (CTIIC), a subsidiary of the main shareholder Triumph, granted the company short-term financing in the amount of € 6.0 million (CTIIC financing) with effect from August 19, 2024. This has been drawn down in full and is available until September 30, 2025.

In addition, the company has access to a senior secured loan ("Super Senior Loan") in the amount of € 4.0 million. In May 2023, the company drew down the first tranche of € 2.0 million and in January 2024 the second tranche of € 2.0 million. The current term of the loan tranches is until March 31, 2026.

Furthermore, at the end of the 2024 fiscal year, a lender granted the Company unsecured working capital financing of an additional € 2.0 million, which was initially due for repayment on March 31, 2025. The Executive Board has extended the term of this loan with the lender until March 31, 2026.

Despite the positive planning assessment, there is significant uncertainty in accordance with Section 322 (2) sentence 3 HGB. This relates in particular to the dependence on project progress, partial payments, refinancing, and the potential impact of external factors such as an intensified customs dispute.

Events After the Balance Sheet Date

No reportable events occurred after the balance sheet date.

Shareholdings of Members of the Executive Bodies

As of the balance sheet date, the members of the Executive Board and Supervisory Board of SINGULUS TECHNOLOGIES AG held the following number of shares, convertible bonds and stock options:

	June 30, 2025 Shares
Markus Ehret, Board Member	43
Total	43

AFFIRMATION OF THE LEGAL REPRESENTATIVES

"To the best of our knowledge, we certify that, in accordance with the applicable accounting principles for interim reporting, the consolidated interim financial statements give a true and fair view of the net assets, financial position, and results of operations of the Group. The interim group management report presents the course of business, including the results of operations and the position of the Group, in such a way that it provides a true and fair view and describes the significant opportunities and risks associated with the Group's anticipated developments in the remaining fiscal year."

Kahl am Main, August 2025

The Executive Board

CORPORATE CALENDAR 2025 FINANCIAL KEY FIGURES FOR THE SECOND QUARTER

(preliminary and unaudited)

		2025	2024
Revenue (gross)	million €	14.9	20.1
Order intake	million €	14.7	19.1
EBIT	million €	-1.8	0.5
EBITDA	million €	-1.2	1.2
Earnings before taxes	million €	-1.9	-0.2
Profit/loss for the period	million €	-1.8	-0.2
Research & development expenditures	million €	1.4	1.9

FINANCIAL KEY FIGURES FOR THE FIRST HALF YEAR

(preliminary and unaudited)

		2025	2024
Revenue (gross)	million €	31.3	40.7
Order intake	million €	21.1	52.3
Order backlog (06/30)	million €	67.2	70.4
EBIT	million €	-1.3	1.2
EBITDA	million €	-0.2	2.5
Earnings before taxes	million €	-2.2	-0.3
Profit/loss for the period	million €	-2.1	-0.2
Operating cash flow	million €	-1.4	-7.6
Shareholders' equity	million €	-51.7	-44.8
Balance sheet total	million €	57.9	66.2
Research & development expenditures	million €	2.3	2.6
Employees (06/30)		288	292
Weighted number of shares, basic	million €	8,896,527	8,896,527
Earnings per share, basic	million €	-0.24	-0.02

August 2025

Half Year Report 2025	8/13
September 2025
Equity Forum – German Fall Conference
Flemings Selection Hotel, Frankfurt /Main	9/2
September 2025
"High-Tech Engineering" Investor Conference
MWB Research, www.research-hub.de	9/16
November 2025
Interim Report Q3-2025	11/12

FUTURE-ORIENTED STATEMENTS AND FORECASTS

This report contains future-oriented statements based on the current expectations, assessments and forecasts of the Executive Board as well as on the currently available information to them. Known as well as unknown risks, uncertainties and impacts could cause the actual results, the financial situationor the development to differ from the statements made in this report. We assume no obligation to update the future-oriented statements made in this report.

SINGULUS TECHNOLOGIES AG

Hanauer Landstrasse 103 D-63796 Kahl am Main Tel. +49 6188 440-0 Fax +49 6188 440-1110 Internet: www.singulus.de

Investor Relations Maren Schuster Tel. +49 6188 440-1612 Fax +49 6188 440-1110 investor.relations@singulus.de